mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |